Validation of the Vulnerable Elders Survey-13 (VES-13) in hospitalized older patients

被引:6
|
作者
Kroc, L. [1 ]
Socha, K. [1 ]
Soltysik, B. K. [1 ]
Cieslak-Skubel, A. [1 ]
Piechocka-Wochniak, E. [1 ]
Blaszczak, R. [1 ]
Kostka, T. [1 ]
机构
[1] Med Univ Lodz, Dept Geriatr, Lodz, Poland
关键词
Elderly; Screening; CGA; Functional status; Vulnerability; Frailty; COMPREHENSIVE GERIATRIC ASSESSMENT; MINI-MENTAL-STATE; SCREENING INSTRUMENTS; FUNCTIONAL DECLINE; CANCER; FRAILTY; PEOPLE; FEASIBILITY; MORTALITY; COMMUNITY;
D O I
10.1016/j.eurger.2016.03.008
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To compare the Vulnerable Elders Survey-13 (VES-13) scale, a screening tool for older patients, with four other popular indicators that describe the physical and mental state of patients, the Activities of Daily Living (ADL), Instrumental Activities of Daily Living (IADL), Mini Mental State Examination (MMSE) and Geriatric Depression Scale (GDS), and to determine which cut-off points of the VES-13 scale will be useful for health services. Methods: The study included 864 older Caucasian people (mean age 80.9 +/- 8.2 years, 615 female) who were hospitalized in the Geriatric University Clinic. The VES-13, ADL, IADL, MMSE and GDS were conducted in all the patients. A "gold standard'' was created as a composite reference value assuming a non-vulnerable person with satisfactory results of all the reference tests: ADL (>= 5), IADL (>= 7), MMSE (>= 24) and GDS (< 6). Results: Significant statistical correlations between the VES 13 and age (r = 0.59), ADL (r = -0.53), IADL (r = -0.66), MMSE (r = -0.47) and GDS (r = 0.37) were found. The sensitivity and specificity in detecting risk of functional vulnerability were 91.2% and 2.3%, 91.9% and 48.7%, 80.6% and 70.8%, 76.8% and 74.9%, and 71.6% and 82.2% for VES-13 scores of >= 3, >= 4, >= 5, >= 6, and >= 7, respectively. The Area Under the Curve (AUC) for the Receiver Operating Characteristic (ROC) was 82.6%. Conclusion: The VES-13 demonstrates high sensitivity and specificity in detecting functional deficits in older subjects. High correlations with other measures of Comprehensive Geriatric Assessment make it a valuable screening tool for older patients. A cut-off point of 6 seems optimal for screening purposes by health services. (C) 2016 Elsevier Masson SAS and European Union Geriatric Medicine Society. All rights reserved.
引用
收藏
页码:449 / 453
页数:5
相关论文
共 50 条
  • [1] Validation of the French version of the Vulnerable Elders Survey-13 (VES-13)
    Joël Belmin
    Lyamna Khellaf
    Sylvie Pariel
    Witold Jarzebowski
    Lucie Valembois
    John Zeisel
    Carmelo Lafuente-Lafuente
    [J]. BMC Medical Research Methodology, 20
  • [2] Validation of the French version of the Vulnerable Elders Survey-13 (VES-13)
    Belmin, Joel
    Khellaf, Lyamna
    Pariel, Sylvie
    Jarzebowski, Witold
    Valembois, Lucie
    Zeisel, John
    Lafuente-Lafuente, Carmelo
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
  • [3] Psychometric properties of the Brazilian version of the Vulnerable Elders Survey-13 (VES-13)
    Luz, Laercio Lima
    Santiago, Livia Maria
    Santos da Silva, Joao Francisco
    Mattos, Ines Echenique
    [J]. CADERNOS DE SAUDE PUBLICA, 2015, 31 (03): : 507 - 515
  • [4] Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)
    Luciani, Andrea
    Biganzoli, Laura
    Colloca, Giuseppe
    Falci, Cristina
    Castagneto, Bruno
    Floriani, Irene
    Battisti, Nicolo
    Dottorini, Lorenzo
    Ferrari, Daris
    Fiduccia, Pasquale
    Zafarana, Elena
    Del Monte, Francesca
    Galli, Francesca
    Monfardini, Silvio
    Foa, Paolo
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2015, 6 (04) : 272 - 279
  • [5] Cross-Cultural Adaptation of the Vulnerable Elders Survey-13(VES-13): helping in the identification of vulnerable older people
    Motta Maia, Flavia de Oliveira
    de Oliveira Duarte, Yeda Aparecida
    Secoli, Silvia Regina
    Ferreira Santos, Jair Licio
    Lebrao, Maria Lucia
    [J]. REVISTA DA ESCOLA DE ENFERMAGEM DA USP, 2012, 46 : 116 - 122
  • [6] A prospective study to evaluate the Vulnerable Elders Survey-13 (VES-13) as a tool to identify frail older cancer patients (pts).
    Biganzoli, Laura
    Tenori, Leonardo
    Zafarana, Elena
    Becheri, Dimitri
    Biagioni, Chiara
    Cappadona, Silvia
    Brunello, Antonella
    Luciani, Andrea
    Turner, Natalie Heather
    Sanna, Giuseppina
    Di Donato, Samantha
    Luchinat, Claudio
    Di Leo, Angelo
    Boni, Luca
    Mottino, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Cancer, Functional Decline, and the Vulnerable Elders Survey (VES-13) in Older Medicare Beneficiaries.
    Wroe, P.
    Naeim, A.
    Dale, W.
    Fan, L.
    Mohile, S.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2012, 60 : S104 - S104
  • [8] A pilot study of the Vulnerable Elders Survey-13 (VES-13) as compared to Comprehensive Geriatric Assessment (CGA) to examine geriatric domains in older prostate cancer patients at risk for decline.
    Mohile, S. G.
    Bylow, K.
    Stadler, W. M.
    Rodin, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 477S - 477S
  • [9] Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
    Fama, Angelo
    Martin, Peter
    Allmer, Cristine
    Casulo, Carla
    Cohen, Jonathon B.
    Farooq, Umar
    Feldman, Andrew L.
    Friedberg, Jonathan W.
    Habermann, Thomas M.
    Jaye, David L.
    Kahl, Brad S.
    Link, Brian K.
    Lossos, Izidore S.
    Maurer, Matthew J.
    Nastoupil, Loretta J.
    Rutherford, Sarah C.
    Slager, Susan L.
    Thompson, Carrie A.
    Flowers, Christopher R.
    Cerhan, James R.
    [J]. BLOOD, 2019, 134
  • [10] Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?
    Biganzoli, L.
    Boni, L.
    Becheri, D.
    Zafarana, E.
    Biagioni, C.
    Cappadona, S.
    Bianchini, E.
    Oakman, C.
    Magnolfi, S. U.
    Di Leo, A.
    Mottino, G.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (02) : 494 - 500